| Cannabinoid receptors CB1 and CB2 form functional heteromers in brain L Callén, E Moreno, P Barroso-Chinea, D Moreno-Delgado, A Cortés, ... Journal of Biological Chemistry 287 (25), 20851-20865, 2012 | 330 | 2012 |
| Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors MR Pazos, N Mohammed, H Lafuente, M Santos, E Martínez-Pinilla, ... Neuropharmacology 71, 282-291, 2013 | 259 | 2013 |
| Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors X Viñals, E Moreno, L Lanfumey, A Cordomí, A Pastor, R de La Torre, ... PLoS biology 13 (7), e1002194, 2015 | 232 | 2015 |
| Circadian-Related Heteromerization of Adrenergic and Dopamine D4 Receptors Modulates Melatonin Synthesis and Release in the Pineal Gland S González, D Moreno-Delgado, E Moreno, K Pérez-Capote, R Franco, ... PLoS biology 10 (6), e1001347, 2012 | 194 | 2012 |
| Direct involvement of σ-1 receptors in the dopamine D1 receptor-mediated effects of cocaine G Navarro, E Moreno, M Aymerich, D Marcellino, PJ McCormick, J Mallol, ... Proceedings of the National Academy of Sciences 107 (43), 18676-18681, 2010 | 190 | 2010 |
| Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors C Ferrada, E Moreno, V Casadó, G Bongers, A Cortés, J Mallol, EI Canela, ... British journal of pharmacology 157 (1), 64-75, 2009 | 187 | 2009 |
| Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer J Bonaventura, G Navarro, V Casadó-Anguera, K Azdad, W Rea, ... Proceedings of the National Academy of Sciences 112 (27), E3609-E3618, 2015 | 175 | 2015 |
| Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling E Moreno, C Andradas, M Medrano, MM Caffarel, E Pérez-Gómez, ... Journal of Biological Chemistry 289 (32), 21960-21972, 2014 | 145 | 2014 |
| Cocaine Inhibits Dopamine D2 Receptor Signaling via Sigma-1-D2 Receptor Heteromers G Navarro, E Moreno, J Bonaventura, M Brugarolas, D Farre, D Aguinaga, ... PloS one 8 (4), e61245, 2013 | 145 | 2013 |
| Functional selectivity of allosteric interactions within G protein–coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer X Guitart, G Navarro, E Moreno, H Yano, NS Cai, M Sánchez-Soto, ... Molecular pharmacology 86 (4), 417-429, 2014 | 141 | 2014 |
| Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway E Moreno, H Hoffmann, M Gonzalez-Sepulveda, G Navarro, V Casado, ... Journal of Biological Chemistry 286 (7), 5846-5854, 2011 | 141 | 2011 |
| Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers G Navarro, S Ferré, A Cordomi, E Moreno, J Mallol, V Casadó, A Cortés, ... Journal of Biological Chemistry 285 (35), 27346-27359, 2010 | 136 | 2010 |
| Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs G Navarro, A Cordomí, M Zelman-Femiak, M Brugarolas, E Moreno, ... BMC biology 14, 1-12, 2016 | 134 | 2016 |
| Dopamine D4 receptor, but not the ADHD-associated D4. 7 variant, forms functional heteromers with the dopamine D2S receptor in the brain S González, C Rangel-Barajas, M Peper, R Lorenzo, E Moreno, F Ciruela, ... Molecular psychiatry 17 (6), 650-662, 2012 | 132 | 2012 |
| The endocannabinoid system as a target in cancer diseases: are we there yet? E Moreno, M Cavic, A Krivokuca, V Casadó, E Canela Frontiers in pharmacology 10, 339, 2019 | 128 | 2019 |
| Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase G Navarro, A Cordomí, V Casadó-Anguera, E Moreno, NS Cai, A Cortés, ... Nature communications 9 (1), 1242, 2018 | 128 | 2018 |
| Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer E Pérez-Gómez, C Andradas, S Blasco-Benito, MM Caffarel, ... Journal of the National Cancer Institute 107 (6), djv077, 2015 | 127 | 2015 |
| Allosteric mechanisms within the adenosine A2A–dopamine D2 receptor heterotetramer S Ferré, J Bonaventura, D Tomasi, G Navarro, E Moreno, A Cortés, ... Neuropharmacology 104, 154-160, 2016 | 115 | 2016 |
| Cross-communication between Gi and Gs in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain G Navarro, A Cordomí, M Brugarolas, E Moreno, D Aguinaga, ... Bmc Biology 16, 1-15, 2018 | 101 | 2018 |
| l-DOPA-treatment in primates disrupts the expression of A2A adenosine–CB1 cannabinoid–D2 dopamine receptor heteromers in the caudate nucleus J Bonaventura, AJ Rico, E Moreno, S Sierra, M Sánchez, N Luquin, ... Neuropharmacology 79, 90-100, 2014 | 101 | 2014 |